Biogen Inc. buy Morgan Stanley
Start price
05.09.23
/
50%
€248.40
Target price
05.09.24
€355.70
Performance (%)
-27.13%
End price
06.09.24
€181.00
Summary
This prediction ended on 06.09.24 with a price of €181.00. The price of Biogen Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -27.13%. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | 6.848% | 6.848% | 9.570% |
| iShares Core DAX® | 2.331% | 5.140% | 25.000% |
| iShares Nasdaq 100 | 2.077% | 2.956% | 8.935% |
| iShares Nikkei 225® | 2.759% | 7.214% | 22.171% |
| iShares S&P 500 | 1.613% | 2.893% | 6.249% |
Comments by Morgan_Stanley for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target raised by analysts at Morgan Stanley from $363.00 to $381.00. They now have an "overweight" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten